Key market opportunities in mutation detection kits for genome editing include addressing rising genetic disorders with ...

Illumina Inc. (NASDAQ:ILMN) ranks among the top NASDAQ stocks with low P/E ratios. On September 23, Illumina Inc. (NASDAQ:ILMN) announced that it would collaborate with several global pharmaceutical ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 13, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Long‑Read Sequencing Services Market Through 2025? The market size for long-read ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...

Since 2019, MIT researchers have published a new concept called prime editing, which is more precise than regular CRISPR-Cas9 gene editing. As a result, it has fewer off-target effects and less chance ...

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

From an end-user perspective, hospitals are projected to hold a dominant 57.3% market share in 2025. Their leading role stems ...

The biotech world has changed a lot in just a few years. From huge investment frenzies to market resets, the industry feels ...

The Broad Institute gene-sequencing lab used Roche equipment to read infants’ DNA genomes in less than four hours, cutting an ...

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...